Helping you navigate long-term care and aging with expert guidance, trusted information, and practical tools.
Explore the full range of long-term care options. From in-home support to assisted living, find straightforward guidance to make informed decisions.
Visit Learning CenterEverything you need to learn about Long-Term Care Insurance in one place. From policy types and benefits to pricing, underwriting, and more.
Visit Learning CenterExplore a range of topics centered around living your best life as you age. Discover practical advice on healthy aging strategies and planning for the future.
All News & TopicsResources and connections for businesses and partners. Access information about LTC News, advertising opportunities, partnerships, and ways to get in touch with our team.
No. The newly cleared test does not predict whether a cognitively healthy person will eventually develop Alzheimer's or when symptoms might begin. Separate research has explored whether p-tau217 could someday help estimate when symptoms may emerge, but that research is different from the FDA-cleared Elecsys test.